Consistent with BRCA2 and ATM showing association with disease severity, their effect sizes were larger in this aggressive prostate cancer versus controls analysis compared to the overall prostate cancer versus controls analysis (Fig. 2 and Table 2). Here, BRCA2 is linked to prostate cancer.